Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease

This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and t...

Full description

Saved in:
Bibliographic Details
Published inmSystems Vol. 10; no. 4; p. e0114824
Main Authors Du, Landuoduo, Zhang, Kaichuang, Liang, Lili, Yang, Yi, Lu, Deyun, Zhou, Yongchang, Ren, Tianyi, Fan, Jiangao, Zhang, Huiwen, Wang, Ying, Jiang, Lu
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 22.04.2025
Subjects
Online AccessGet full text
ISSN2379-5077
2379-5077
DOI10.1128/msystems.01148-24

Cover

Abstract This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.
AbstractList ABSTRACTThe development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.
The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6-16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified and as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography ( ) values (≥6.2 kPa) showed an increased abundance of , which was positively correlated with the levels of deoxycholic acid (DCA) and values. Importantly, the mediation analysis identified positive associations between and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that may serve as a novel clinical target in pediatric MASLD.
ABSTRACT The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.
The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.
The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6-16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6-16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.
The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography ( E ) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques , which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.
This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.
Author Du, Landuoduo
Zhang, Huiwen
Lu, Deyun
Zhou, Yongchang
Fan, Jiangao
Wang, Ying
Zhang, Kaichuang
Liang, Lili
Ren, Tianyi
Jiang, Lu
Yang, Yi
Author_xml – sequence: 1
  givenname: Landuoduo
  orcidid: 0009-0000-9120-441X
  surname: Du
  fullname: Du, Landuoduo
– sequence: 2
  givenname: Kaichuang
  surname: Zhang
  fullname: Zhang, Kaichuang
– sequence: 3
  givenname: Lili
  surname: Liang
  fullname: Liang, Lili
– sequence: 4
  givenname: Yi
  surname: Yang
  fullname: Yang, Yi
– sequence: 5
  givenname: Deyun
  surname: Lu
  fullname: Lu, Deyun
– sequence: 6
  givenname: Yongchang
  surname: Zhou
  fullname: Zhou, Yongchang
– sequence: 7
  givenname: Tianyi
  surname: Ren
  fullname: Ren, Tianyi
– sequence: 8
  givenname: Jiangao
  surname: Fan
  fullname: Fan, Jiangao
– sequence: 9
  givenname: Huiwen
  surname: Zhang
  fullname: Zhang, Huiwen
– sequence: 10
  givenname: Ying
  orcidid: 0000-0001-5587-7772
  surname: Wang
  fullname: Wang, Ying
– sequence: 11
  givenname: Lu
  orcidid: 0000-0003-4522-3614
  surname: Jiang
  fullname: Jiang, Lu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40084870$$D View this record in MEDLINE/PubMed
BookMark eNp1kk9vFSEUxYmpsbX2A7gxJG7czBMYGJiVMY1_mtS40TVh4M57vDBDBabN2_vBpX3tszVxBeH8ODk397xER3OcAaHXlKwoZer9lHe5wJRXhFKuGsafoRPWyr4RRMqjR_djdJbzlhBCu1ZS1r9Ax5wQxZUkJ-j3tyUU38TJ24zNbMIuQ8ZxxGUDeL0UXIUUBx-LqbLDExQzxOBLpfyM7cYHl2DGN75sDqLFbpfHZbbFx7kxOUfrTQGHa2BTYqlA8NeQsPMZTIZX6PloQoaz-_MU_fz86cf51-by-5eL84-XjalhS-Ng5E4RNSoySOU6UQcSIwEnesla0o-GOMcpCFdH69oehFWqZ1xBL5zsWHuKLva-Lpqtvkp-Mmmno_H67iGmtTappgugLSPCWmWcIJZ3vFWcDYPrpBgHYrvh1uvD3utqGSZwFuaSTHhi-lSZ_Uav47WmjNCWSVEd3t07pPhrgVz05LOFEMwMccm6pVJS0SlGK_r2H3Qbl1S3VSlGOOuV7LpKrfaUyRP7S1CibwujHwqj7wqjGa8f3jye4RD-oR4VoHugdiDnBOMB-b_pH2AF0wM
Cites_doi 10.1002/hep.28572
10.1126/sciadv.abg3750
10.1097/MPG.0000000000001482
10.1053/j.gastro.2019.06.028
10.1128/jb.173.2.697-703.1991
10.1038/srep27572
10.1099/00207713-44-4-846
10.1016/j.cell.2016.05.041
10.1038/ajg.2010.281
10.1038/s41467-017-00796-x
10.1097/HC9.0000000000000310
10.1002/hep.26093
10.1186/gb-2011-12-6-r60
10.3389/fmicb.2021.728823
10.1021/acs.analchem.0c04686
10.1038/s41467-020-18476-8
10.1016/j.cmet.2019.08.002
10.1016/j.hbpd.2023.06.006
10.1053/j.gastro.2020.07.005
10.1038/s41467-019-13036-1
10.1038/nmeth.2604
10.1186/s12944-021-01440-w
10.1038/s41575-019-0169-z
10.1128/spectrum.05230-22
10.3390/metabo13101043
10.1148/radiol.14131251
10.3390/cancers12092619
10.2471/blt.07.043497
10.1016/j.jhepr.2021.100387
10.1136/gut.2010.223263
10.1038/s41575-020-0269-9
10.1111/liv.15852
10.1097/HEP.0000000000000520
10.1016/j.cell.2024.02.022
10.1016/j.clnu.2023.11.001
10.1038/s41467-023-36256-y
ContentType Journal Article
Copyright Copyright © 2025 Du et al.
Copyright © 2025 Du et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2025 Du et al. 2025 Du et al.
Copyright_xml – notice: Copyright © 2025 Du et al.
– notice: Copyright © 2025 Du et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2025 Du et al. 2025 Du et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1128/msystems.01148-24
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Biological Science Database
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE


MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2379-5077
Editor Das, Promi
Editor_xml – sequence: 1
  givenname: Promi
  surname: Das
  fullname: Das, Promi
ExternalDocumentID oai_doaj_org_article_c205cc8ad50c4643842bbd675fb0c6b2
PMC12013275
msystems01148-24
40084870
10_1128_msystems_01148_24
Genre Journal Article
GeographicLocations United States--US
China
Shanghai China
GeographicLocations_xml – name: Shanghai China
– name: China
– name: United States--US
GrantInformation_xml – fundername: MOST | National Key Research and Development Program of China (NKPs)
  grantid: 2022YFA1305600
– fundername: STCSM | Natural Science Foundation of Shanghai Municipality ()
  grantid: 23ZR1452600
– fundername: Shanghai Municipal Health Commission ()
  grantid: 20234Z0004
– fundername: STCSM | Natural Science Foundation of Shanghai Municipality ()
  grantid: 22ZR1441100
– fundername: MOST | National Natural Science Foundation of China (NSFC)
  grantid: 82100950
– fundername: STCSM | Natural Science Foundation of Shanghai Municipality (上海市自然科学基金)
  grantid: 22ZR1441100
– fundername: STCSM | Natural Science Foundation of Shanghai Municipality (上海市自然科学基金)
  grantid: 23ZR1452600
– fundername: Shanghai Municipal Health Commission (上海市卫生健康委员会)
  grantid: 20234Z0004
– fundername: ;
  grantid: 23ZR1452600
– fundername: ;
  grantid: 2022YFA1305600
– fundername: ;
  grantid: 20234Z0004
– fundername: ;
  grantid: 82100950
– fundername: ;
  grantid: 22ZR1441100
GroupedDBID 0R~
53G
5VS
7X7
8FE
8FH
8FI
8FJ
AAFWJ
AAGFI
AAUOK
AAYXX
ABUWG
ACPRK
ADBBV
AFKRA
AFPKN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
EBS
FRP
FYUFA
GROUPED_DOAJ
H13
HCIFZ
HMCUK
HYE
KQ8
LK8
M48
M7P
M~E
O9-
OK1
PHGZM
PHGZT
PIMPY
PQGLB
PQQKQ
PROAC
PUEGO
RHI
RPM
RSF
UKHRP
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-a487t-def4d808f80b78d651635f0ed5972309fa0dd41e5d870639e5c889248e95d7623
IEDL.DBID M48
ISSN 2379-5077
IngestDate Wed Aug 27 01:24:13 EDT 2025
Thu Aug 21 18:26:59 EDT 2025
Thu Sep 04 17:52:52 EDT 2025
Fri Jul 25 09:18:37 EDT 2025
Tue Apr 22 18:20:29 EDT 2025
Fri Apr 25 03:24:40 EDT 2025
Wed Sep 10 05:25:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords deoxycholic acid
biomarker
steatosis
Ruminococcus torques
pediatric
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a487t-def4d808f80b78d651635f0ed5972309fa0dd41e5d870639e5c889248e95d7623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Landuoduo Du and Kaichuang Zhang contributed equally to this article. Author order was determined based on the extent of their individual contributions to the different sections of the research and the manuscript preparation.
The authors declare no conflict of interest.
ORCID 0000-0001-5587-7772
0000-0003-4522-3614
0009-0000-9120-441X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1128/msystems.01148-24
PMID 40084870
PQID 3204298766
PQPubID 2045591
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_c205cc8ad50c4643842bbd675fb0c6b2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12013275
proquest_miscellaneous_3177156821
proquest_journals_3204298766
asm2_journals_10_1128_msystems_01148_24
pubmed_primary_40084870
crossref_primary_10_1128_msystems_01148_24
PublicationCentury 2000
PublicationDate 2025-04-22
PublicationDateYYYYMMDD 2025-04-22
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-22
  day: 22
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
– name: Washington
PublicationTitle mSystems
PublicationTitleAbbrev mSystems
PublicationTitleAlternate mSystems
PublicationYear 2025
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_4_3_2
e_1_3_4_2_2
e_1_3_4_9_2
e_1_3_4_8_2
e_1_3_4_7_2
e_1_3_4_6_2
e_1_3_4_5_2
e_1_3_4_4_2
e_1_3_4_22_2
e_1_3_4_23_2
e_1_3_4_20_2
e_1_3_4_21_2
e_1_3_4_26_2
e_1_3_4_27_2
e_1_3_4_24_2
e_1_3_4_25_2
e_1_3_4_28_2
e_1_3_4_29_2
e_1_3_4_30_2
e_1_3_4_11_2
e_1_3_4_34_2
e_1_3_4_12_2
e_1_3_4_33_2
e_1_3_4_32_2
e_1_3_4_10_2
e_1_3_4_31_2
e_1_3_4_15_2
e_1_3_4_38_2
e_1_3_4_16_2
e_1_3_4_37_2
e_1_3_4_13_2
e_1_3_4_36_2
e_1_3_4_14_2
e_1_3_4_35_2
e_1_3_4_19_2
e_1_3_4_17_2
e_1_3_4_18_2
B21
de Onis, M, Onyango, AW, Borghi, E, Siyam, A, Nishida, C, Siekmann, J (B9) 2007; 85
Wang, T, Guo, XK, Xu, H (B34) 2021; 12
Xie, G, Wang, L, Chen, T, Zhou, K, Zhang, Z, Li, J, Sun, B, Guo, Y, Wang, X, Wang, Y, Zhang, H, Liu, P, Nicholson, JK, Ge, W, Jia, W (B17) 2021; 93
Zhu, L, Baker, SS, Gill, C, Liu, W, Alkhouri, R, Baker, RD, Gill, SR (B8) 2013; 57
Deng, K, Xu, JJ, Shen, L, Zhao, H, Gou, W, Xu, F, Fu, Y, Jiang, Z, Shuai, M, Li, BY, Hu, W, Zheng, JS, Chen, YM (B16) 2023; 14
Png, CW, Lindén, SK, Gilshenan, KS, Zoetendal, EG, McSweeney, CS, Sly, LI, McGuckin, MA, Florin, THJ (B18) 2010; 105
Rinella, ME, Lazarus, JV, Ratziu, V, Francque, SM, Sanyal, AJ, Kanwal, F, Romero, D, Abdelmalek, MF, Anstee, QM, Arab, JP (B2) 2023; 78
Younossi, ZM, Golabi, P, Paik, J, Owrangi, S, Yilmaz, Y, El-Kassas, M, Alswat, K, Alqahtani, SA (B1) 2024; 44
Gillard, J, Clerbaux, LA, Nachit, M, Sempoux, C, Staels, B, Bindels, LB, Tailleux, A, Leclercq, IA (B36) 2022; 4
Nobili, V, Alisi, A, Valenti, L, Miele, L, Feldstein, AE, Alkhouri, N (B3) 2019; 16
Gunathilake, M, Lee, J, Choi, IJ, Kim, YI, Yoon, J, Sul, WJ, Kim, JF, Kim, J (B23) 2020; 12
Del Chierico, F, Nobili, V, Vernocchi, P, Russo, A, De Stefanis, C, Gnani, D, Furlanello, C, Zandonà, A, Paci, P, Capuani, G, Dallapiccola, B, Miccheli, A, Alisi, A, Putignani, L (B7) 2017; 65
Edgar, RC (B14) 2013; 10
Suh, CH, Kim, SY, Kim, KW, Lim, YS, Lee, SJ, Lee, MG, Lee, J, Lee, SG, Yu, E (B26) 2014; 271
Xu, J, Zhou, Y, Cheng, S, Zhao, Y, Yan, J, Wang, Y, Cai, W, Jiang, L (B20) 2023; 13
Lang, S, Demir, M, Martin, A, Jiang, L, Zhang, X, Duan, Y, Gao, B, Wisplinghoff, H, Kasper, P, Roderburg, C, Tacke, F, Steffen, HM, Goeser, T, Abraldes, JG, Tu, XM, Loomba, R, Stärkel, P, Pride, D, Fouts, DE, Schnabl, B (B10) 2020; 159
Luo, J, Luo, M, Kaminga, AC, Wei, J, Dai, W, Peng, Y, Zhao, K, Duan, Y, Xiao, X, Ouyang, S, Yao, Z, Liu, Y, Pan, X (B5) 2024; 12
Loomba, R, Seguritan, V, Li, W, Long, T, Klitgord, N, Bhatt, A, Dulai, PS, Caussy, C, Bettencourt, R, Highlander, SK, Jones, MB, Sirlin, CB, Schnabl, B, Brinkac, L, Schork, N, Chen, CH, Brenner, DA, Biggs, W, Yooseph, S, Venter, JC, Nelson, KE (B30) 2019; 30
Zhang, Q, Wu, Y, Wang, J, Wu, G, Long, W, Xue, Z, Wang, L, Zhang, X, Pang, X, Zhao, Y, Zhao, L, Zhang, C (B33) 2016; 6
Weisburg, WG, Barns, SM, Pelletier, DA, Lane, DJ (B11) 1991; 173
Long, Q, Luo, F, Li, B, Li, Z, Guo, Z, Chen, Z, Wu, W, Hu, M (B29) 2024; 8
Schwimmer, JB, Johnson, JS, Angeles, JE, Behling, C, Belt, PH, Borecki, I, Bross, C, Durelle, J, Goyal, NP, Hamilton, G, Holtz, ML, Lavine, JE, Mitreva, M, Newton, KP, Pan, A, Simpson, PM, Sirlin, CB, Sodergren, E, Tyagi, R, Yates, KP, Weinstock, GM, Salzman, NH (B6) 2019; 157
Johnson, JS, Spakowicz, DJ, Hong, B-Y, Petersen, LM, Demkowicz, P, Chen, L, Leopold, SR, Hanson, BM, Agresta, HO, Gerstein, M, Sodergren, E, Weinstock, GM (B12) 2019; 10
Joossens, M, Huys, G, Cnockaert, M, De Preter, V, Verbeke, K, Rutgeerts, P, Vandamme, P, Vermeire, S (B37) 2011; 60
Wu, MY, Fan, JG (B27) 2023; 22
Aron-Wisnewsky, J, Vigliotti, C, Witjes, J, Le, P, Holleboom, AG, Verheij, J, Nieuwdorp, M, Clément, K (B4) 2020; 17
Segata, N, Izard, J, Waldron, L, Gevers, D, Miropolsky, L, Garrett, WS, Huttenhower, C (B24) 2011; 12
Gupta, VK, Kim, M, Bakshi, U, Cunningham, KY, Davis, JM, Lazaridis, KN, Nelson, H, Chia, N, Sung, J (B22) 2020; 11
Wu, R, Guo, W, Qiu, X, Wang, S, Sui, C, Lian, Q, Wu, J, Shan, Y, Yang, Z, Yang, S (B35) 2021; 7
Koh, A, De Vadder, F, Kovatcheva-Datchary, P, Bäckhed, F (B32) 2016; 165
Li, F, Ye, J, Shao, C, Zhong, B (B28) 2021; 20
Llorente, C, Jepsen, P, Inamine, T, Wang, L, Bluemel, S, Wang, HJ, Loomba, R, Bajaj, JS, Schubert, ML, Sikaroodi, M, Gillevet, PM, Xu, J, Kisseleva, T, Ho, SB, DePew, J, Du, X, Sørensen, HT, Vilstrup, H, Nelson, KE, Brenner, DA, Fouts, DE, Schnabl, B (B19) 2017; 8
Stackebrandt, E, Goebel, BM (B15) 1994; 44
Jia, D, Wang, Q, Qi, Y, Jiang, Y, He, J, Lin, Y, Sun, Y, Xu, J, Chen, W, Fan, L, Yan, R, Zhang, W, Ren, G, Xu, C, Ge, Q, Wang, L, Liu, W, Xu, F, Wu, P, Wang, Y, Chen, S, Wang, L (B13) 2024; 187
Vos, MB, Abrams, SH, Barlow, SE, Caprio, S, Daniels, SR, Kohli, R, Mouzaki, M, Sathya, P, Schwimmer, JB, Sundaram, SS, Xanthakos, SA (B25) 2017; 64
Ji, J, Sun, J, Li, J, Xie, J, Xi, B, Zhao, M (B31) 2024; 43
References_xml – ident: e_1_3_4_8_2
  doi: 10.1002/hep.28572
– ident: e_1_3_4_36_2
  doi: 10.1126/sciadv.abg3750
– ident: e_1_3_4_26_2
  doi: 10.1097/MPG.0000000000001482
– ident: e_1_3_4_7_2
  doi: 10.1053/j.gastro.2019.06.028
– ident: e_1_3_4_12_2
  doi: 10.1128/jb.173.2.697-703.1991
– ident: e_1_3_4_34_2
  doi: 10.1038/srep27572
– ident: e_1_3_4_16_2
  doi: 10.1099/00207713-44-4-846
– ident: e_1_3_4_33_2
  doi: 10.1016/j.cell.2016.05.041
– ident: e_1_3_4_19_2
  doi: 10.1038/ajg.2010.281
– ident: e_1_3_4_20_2
  doi: 10.1038/s41467-017-00796-x
– ident: e_1_3_4_30_2
  doi: 10.1097/HC9.0000000000000310
– ident: e_1_3_4_9_2
  doi: 10.1002/hep.26093
– ident: e_1_3_4_25_2
  doi: 10.1186/gb-2011-12-6-r60
– ident: e_1_3_4_35_2
  doi: 10.3389/fmicb.2021.728823
– ident: e_1_3_4_18_2
  doi: 10.1021/acs.analchem.0c04686
– ident: e_1_3_4_22_2
– ident: e_1_3_4_23_2
  doi: 10.1038/s41467-020-18476-8
– ident: e_1_3_4_31_2
  doi: 10.1016/j.cmet.2019.08.002
– ident: e_1_3_4_28_2
  doi: 10.1016/j.hbpd.2023.06.006
– ident: e_1_3_4_11_2
  doi: 10.1053/j.gastro.2020.07.005
– ident: e_1_3_4_13_2
  doi: 10.1038/s41467-019-13036-1
– ident: e_1_3_4_15_2
  doi: 10.1038/nmeth.2604
– ident: e_1_3_4_29_2
  doi: 10.1186/s12944-021-01440-w
– ident: e_1_3_4_4_2
  doi: 10.1038/s41575-019-0169-z
– ident: e_1_3_4_6_2
  doi: 10.1128/spectrum.05230-22
– ident: e_1_3_4_21_2
  doi: 10.3390/metabo13101043
– ident: e_1_3_4_27_2
  doi: 10.1148/radiol.14131251
– ident: e_1_3_4_24_2
  doi: 10.3390/cancers12092619
– ident: e_1_3_4_10_2
  doi: 10.2471/blt.07.043497
– ident: e_1_3_4_37_2
  doi: 10.1016/j.jhepr.2021.100387
– ident: e_1_3_4_38_2
  doi: 10.1136/gut.2010.223263
– ident: e_1_3_4_5_2
  doi: 10.1038/s41575-020-0269-9
– ident: e_1_3_4_2_2
  doi: 10.1111/liv.15852
– ident: e_1_3_4_3_2
  doi: 10.1097/HEP.0000000000000520
– ident: e_1_3_4_14_2
  doi: 10.1016/j.cell.2024.02.022
– ident: e_1_3_4_32_2
  doi: 10.1016/j.clnu.2023.11.001
– ident: e_1_3_4_17_2
  doi: 10.1038/s41467-023-36256-y
– volume: 64
  start-page: 319
  year: 2017
  end-page: 334
  ident: B25
  article-title: NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/MPG.0000000000001482
– volume: 8
  start-page: 1
  year: 2024
  ident: B29
  article-title: Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease
  publication-title: Hepatol Commun
  doi: 10.1097/HC9.0000000000000310
– volume: 12
  year: 2024
  ident: B5
  article-title: Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children
  publication-title: Microbiol Spectr
  doi: 10.1128/spectrum.05230-22
– volume: 78
  start-page: 1966
  year: 2023
  end-page: 1986
  ident: B2
  article-title: A multisociety Delphi consensus statement on new fatty liver disease nomenclature
  publication-title: Hepatology
  doi: 10.1097/HEP.0000000000000520
– volume: 13
  start-page: 1043
  year: 2023
  ident: B20
  article-title: Lactobacillus johnsonii attenuates liver steatosis and bile acid dysregulation in parenteral nutrition-fed rats
  publication-title: Metabolites
  doi: 10.3390/metabo13101043
– volume: 12
  start-page: 728823
  year: 2021
  ident: B34
  article-title: Disentangling the progression of non-alcoholic fatty liver disease in the human gut microbiota
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2021.728823
– volume: 159
  start-page: 1839
  year: 2020
  end-page: 1852
  ident: B10
  article-title: Intestinal virome signature associated with severity of nonalcoholic fatty liver disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.07.005
– volume: 17
  start-page: 279
  year: 2020
  end-page: 297
  ident: B4
  article-title: Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-020-0269-9
– volume: 165
  start-page: 1332
  year: 2016
  end-page: 1345
  ident: B32
  article-title: From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites
  publication-title: Cell
  doi: 10.1016/j.cell.2016.05.041
– volume: 85
  start-page: 660
  year: 2007
  end-page: 667
  ident: B9
  article-title: Development of a WHO growth reference for school-aged children and adolescents
  publication-title: Bull World Health Organ
  doi: 10.2471/blt.07.043497
– volume: 173
  start-page: 697
  year: 1991
  end-page: 703
  ident: B11
  article-title: 16S ribosomal DNA amplification for phylogenetic study
  publication-title: J Bacteriol
  doi: 10.1128/jb.173.2.697-703.1991
– volume: 11
  year: 2020
  ident: B22
  article-title: A predictive index for health status using species-level gut microbiome profiling
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-18476-8
– volume: 157
  start-page: 1109
  year: 2019
  end-page: 1122
  ident: B6
  article-title: Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.06.028
– volume: 93
  start-page: 5709
  year: 2021
  end-page: 5717
  ident: B17
  article-title: A metabolite array technology for precision medicine
  publication-title: Anal Chem
  doi: 10.1021/acs.analchem.0c04686
– volume: 271
  start-page: 895
  year: 2014
  end-page: 900
  ident: B26
  article-title: Determination of normal hepatic elasticity by using real-time shear-wave elastography
  publication-title: Radiology
  doi: 10.1148/radiol.14131251
– volume: 22
  start-page: 444
  year: 2023
  end-page: 451
  ident: B27
  article-title: Gut microbiome and nonalcoholic fatty liver disease
  publication-title: Hepatobiliary Pancreat Dis Int
  doi: 10.1016/j.hbpd.2023.06.006
– volume: 57
  start-page: 601
  year: 2013
  end-page: 609
  ident: B8
  article-title: Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH
  publication-title: Hepatology
  doi: 10.1002/hep.26093
– volume: 44
  start-page: 1061
  year: 2024
  end-page: 1070
  ident: B1
  article-title: Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa
  publication-title: Liver Int
  doi: 10.1111/liv.15852
– volume: 12
  year: 2011
  ident: B24
  article-title: Metagenomic biomarker discovery and explanation
  publication-title: Genome Biol
  doi: 10.1186/gb-2011-12-6-r60
– volume: 44
  start-page: 846
  year: 1994
  end-page: 849
  ident: B15
  article-title: Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology
  publication-title: Int J Syst Evol Microbiol
  doi: 10.1099/00207713-44-4-846
– volume: 7
  year: 2021
  ident: B35
  article-title: Comprehensive analysis of spatial architecture in primary liver cancer
  publication-title: Sci Adv
  doi: 10.1126/sciadv.abg3750
– volume: 6
  start-page: 27572
  year: 2016
  ident: B33
  article-title: Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
  publication-title: Sci Rep
  doi: 10.1038/srep27572
– volume: 43
  start-page: 187
  year: 2024
  end-page: 196
  ident: B31
  article-title: Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2023.11.001
– volume: 10
  start-page: 996
  year: 2013
  end-page: 998
  ident: B14
  article-title: UPARSE: highly accurate OTU sequences from microbial amplicon reads
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2604
– volume: 105
  start-page: 2420
  year: 2010
  end-page: 2428
  ident: B18
  article-title: Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2010.281
– volume: 12
  year: 2020
  ident: B23
  article-title: Alterations in gastric microbial communities are associated with risk of gastric cancer in a korean population: a case-control study
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12092619
– volume: 20
  year: 2021
  ident: B28
  article-title: Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-021-01440-w
– volume: 187
  start-page: 1651
  year: 2024
  end-page: 1665
  ident: B13
  article-title: Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2024.02.022
– volume: 16
  start-page: 517
  year: 2019
  end-page: 530
  ident: B3
  article-title: NAFLD in children: new genes, new diagnostic modalities and new drugs
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0169-z
– volume: 14
  year: 2023
  ident: B16
  article-title: Comparison of fecal and blood metabolome reveals inconsistent associations of the gut microbiota with cardiometabolic diseases
  publication-title: Nat Commun
  doi: 10.1038/s41467-023-36256-y
– volume: 4
  year: 2022
  ident: B36
  article-title: Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
  publication-title: JHEP Rep
  doi: 10.1016/j.jhepr.2021.100387
– volume: 60
  start-page: 631
  year: 2011
  end-page: 637
  ident: B37
  article-title: Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
  publication-title: Gut
  doi: 10.1136/gut.2010.223263
– volume: 8
  year: 2017
  ident: B19
  article-title: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-00796-x
– ident: B21
  article-title: Oksanen J , Simpson G , Blanchet FG , Kindt R , Legendre P , Minchin P , Hara R , Solymos P , Stevens H , Szöcs E , Wagner H , Barbour M , Bedward M , Bolker B , Borcard D , Carvalho G , Chirico M , De Cáceres M , Durand S . 2022 . Vegan community ecology package version 2.6-2 April 2022
– volume: 65
  start-page: 451
  year: 2017
  end-page: 464
  ident: B7
  article-title: Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach
  publication-title: Hepatology
  doi: 10.1002/hep.28572
– volume: 10
  start-page: 5029
  year: 2019
  ident: B12
  article-title: Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-13036-1
– volume: 30
  start-page: 607
  year: 2019
  ident: B30
  article-title: Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.08.002
SSID ssj0001637129
Score 2.2956638
Snippet This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver...
The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut...
ABSTRACTThe development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut...
ABSTRACT The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut...
SourceID doaj
pubmedcentral
proquest
asm2
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0114824
SubjectTerms Adolescent
Alanine transaminase
biomarker
Biomarkers - metabolism
Body mass index
Case-Control Studies
Child
Children
Children & youth
Clinical Microbiology
Deoxycholic acid
DNA sequencing
Fatty Liver - metabolism
Fatty Liver - microbiology
Feces
Feces - microbiology
Female
Gastrointestinal Microbiome
Gut microbiota
Homogenization
Humans
Intestinal microflora
Liver diseases
Male
Metabolism
Metabolites
Metabolomics
Metabolomics - methods
Microbiota
Multiomics
Non-alcoholic Fatty Liver Disease - metabolism
Non-alcoholic Fatty Liver Disease - microbiology
Obesity
Patients
pediatric
Pediatrics
Research Article
Ribosomal DNA
Ruminococcus
Ruminococcus torques
Software
steatosis
Taxonomy
Variance analysis
SummonAdditionalLinks – databaseName: American Society for Microbiology Open Access
  dbid: AAUOK
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_OPQRfxG97nhJBEIScaZo06eMqHoeivrhwbyVf1YXbrtjuw73fH-4k_ThXDvG1k9Ihv5nMTCczA_DKKJcHYxy1QRoqhC2orhxGrU1ubK4KYUwsFP78pTxbiY_n8vwAyqkWZtzB7sR0m5TInzWb67ebobtxd5K8eMrFLTiUaK_EAg6Xy9XXT9d_V8pCoSUb05g3votnMH6D79mj1Lb_Jl_z7yuTf9ig03twd3QeyXJA-z4chPYB3B7GSV4-hKtUTUtjnXFHTOo2EjqybQg6eeT7rieb9dB2qTdI9mQTehSBWITckXVLprpuEv_NzkRH_GUXrV9EkJoRzeBJFI9-i5yQi3i3g4ypnkewOv3w7f0ZHacsUIPBSk99aITXTDeaWaV9KXHvZMOCl3EgGasaw7wXeZA-pkSLKkinNUZtOlTS41FaPIZFu23DUyC6YpUK6MLlPja1USYPmqmgrciVKWWRweu45fUEcp0iEK7rCZw6gVNzkcGbCZX659B241-L30Xc5oWxY3Z6gPJTjwpYO86kc9p4yZxAN0wLbq3HcKmxzJWWZ3A8oX7NX8GjvUaDUWbwciajAsasimnDdodrcqUwCNY8z-DJICQzJyKNK1AsA70nPnus7lPa9Y_U5DvnMQum5NF_79kzuMPjcGImKOfHsOh_7cJz9Jh6-2JUj99-HBgb
  priority: 102
  providerName: American Society for Microbiology
– databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_lgdCL-FHr1loiFAQhNskmm-xRi6UIemqhtyVfqw98-8Tdd-i9f7gz2X2v7xXRi9edHGYzk8xMZuY3hJw6E0RyLjCftGNK-ZLZOkDU2grnhSmVc9go_OVrdXmtPt_om61RX1gTNsIDjxt3FiTXIVgXNQ8KzKdV0vsIbm7reah8vn15zbeCqfy6UpUGLNmUxoQ7-GwxIiP373MEwLDDfeb6hdyxRxm2_0--5sOSyS0bdPGEPJ6cR_phZPop2UvdM_JoHCd5-5zc5W5ahn3GPXUZbST1dNlScPLot9VAF_MRdmlwQI50kQZQAWxC7um8o-u-bopvsxtioPG2R-uHEmRukmaKFNVjWAIn9AfWdtAp1XNAri8-XZ1fsmnKAnMQrAwsplZFy21ruTc2Vhr2Trc8RY0DyXjdOh6jEklHTImWddLBWojabKp1hKu0fEFm3bJLLwm1Na9NAhdORAS1MU4ky02yXgnjKl0W5C1ueTMdk77JEYi0zVo4TRZOI1VB3q2l0vwcYTf-tvgjym2zEBGz8wfQo2bSo-ZfelSQ47XU7_krJdprMBhVQd5syHAAMaviurRcwRphDATBVoqCHI5KsuFE5XEFhhfE7qjPDqu7lG7-PYN8C4lZMKOP_sfPvSL7EucWc8WkPCaz4dcqvQZnavAn-dz8BukaIM0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Ni9UwMOhbBC_it9VVIgiCEDdNkyY9iSu7LIKLiAt7K2mSrg987brtO-zdH-5Mmr7nE9lrZw5D53smM0PIG6tdHqx1rAnKMimbgpnKQdba5rbJdSGtxUHhL6flyZn8fK7OU8FtSM8qZ5sYDbXvHdbIDwqBphN0t_xw-Yvh1SjsrqYTGrfJHphgA3K-d3h0-vXbtspSFho8WmpnAsrBatqQPLyPmQDDSfeFHVZixy_F9f3_izn_fTr5ly86vk_upSCSfpy4_oDcCt1Dcmc6K3n9iPyOU7UM540HauPWkTDQvqUQ7NGL9UhXy2n90mgB7OkqjCAKOIw80GVH5_luijXaDdBRfz2gF0ROMpu4GjxFMRl7oIT-xDceNLV8HpOz46Pvn05YurbALCQtI_Ohld5w0xreaONLBf9OtTx4hYfJeNVa7r3Mg_LYGi2qoJwxkL2ZUCkPJrV4QhZd34VnhJqKVzpAKJd7XG6jbR4M18E0Mte2VEVG3uIvr5O6DHXMRISpZ-bUkTm1kBl5N3OlvpzWb9yEfIh82yDi5uz4ob-6qJMi1k5w5ZyxXnEnIRwzUjSNh7SpbbgrG5GR_ZnrW_q2wpeR1xswKCJ2V2wX-jXg5FpDMmxEnpGnk5BsKJHxbIHmGTE74rND6i6kW_6Iy75zgd0wrZ7fTNcLclfgZWIumRD7ZDFercNLCJfG5lXSiT9muxlf
  priority: 102
  providerName: ProQuest
Title Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease
URI https://www.ncbi.nlm.nih.gov/pubmed/40084870
https://journals.asm.org/doi/10.1128/msystems.01148-24
https://www.proquest.com/docview/3204298766
https://www.proquest.com/docview/3177156821
https://pubmed.ncbi.nlm.nih.gov/PMC12013275
https://doaj.org/article/c205cc8ad50c4643842bbd675fb0c6b2
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_u9lDuRfw8q-cSQRCEnmmaNOmDyJ7ccSh3iriwbyVt0nPhttVtF9x3_3Anabu6svjgU6FJYZiPzkwm8xuAF1oWkdW6CHMrdMh5HocqLTBrLSOdRzLmWrtG4cur5GLK38_EbA-G8VY9A5udqZ2bJzVd3pz8-L5-iwb_pmuAUa8XHehxc-KD-5DxfThAx5S4XOyyj_b9kUsSS3RvfW1z55eHcJt7iHk3vHikmwXb8lce1n9XLPr3lco_fNT5XbjTB5dk0mnDPdiz1X241Y2bXD-An77bNnR9yA3RHo3ENqQuCQaB5HrVksW8g2VqNS4bsrAtqohrUm7IvCJD3zdxZ7ebxYKYdeO8o5NwqHtpW0Oc-rQ1UkJu3N0P0peCHsL0_OzLu4uwn8IQamRDGxpbcqOoKhXNpTKJQDaKkloj3MAympaaGsMjK4wrmcapFYVSmNUpmwqDv9r4EYyqurKPgaiUptJiiBcZB3ojdWQVlVblPJI6EXEALx3Ls0ELMp-hMJUNcsq8nDLGA3g1SCX71sFy_GvzqZPbZqND1PYv6uV11htoVjAqikJpI2jBMUxTnOW5wXSqzGmR5CyA40Hqv-mLmfPn6FCSAJ5vltFAXdVFV7Ze4Z5ISkySFYsCOOqUZEPJoGsBqC312SJ1e6Waf_Ug4BFzVTIpnvz_p0_hkLlpxpSHjB3DqF2u7DMMsdp8DPtyJsdwMJlMP37A5-nZ1afPY39gMfZG9Qv8iC8c
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiDeBAkYCISGFOo4dOweEKLTa0ocQaqXeUsd2ykpsUpqs0N75PfxGZvLYZRHqrdcdKxrtfPPyeGYIeWmUjbwxNsy9NKEQeRzq1ELWWkQmj1QsjMFG4YPDZHwsPp_IkzXye-iFwWeVg01sDbWrLN6Rb8YcTSfobvL-_EeIW6Owujqs0OhgsefnPyFlq9_tfgL5vuJ8Z_vo4zjstwqEBoLzJnS-EE4zXWiWK-0SCRGJLJh3EhdwsbQwzDkReemwBBinXlqtIUvRPpUOTEcM371G1gV2tI7I-tb24Zevy1udJFbgQfvyKdj-zWk3kbl-22YeIXbWj0w95St-sF0X8L8Y99-nmn_5vp3b5FYftNIPHcrukDVf3iXXuzWW83vkV9vFG2J_c01NO-XE17QqKASX9GzW0OmkG_fUGCA7OvUNQA-bn2s6KenQT07xTnhBtNTNa_S6iJzQ9CjyjiIsmwo4od_xTQntS0z3yfGVyOEBGZVV6R8RqlOWKg-hY-RwmI4ykddMeZ2LSJlExgF5jX951qtnnbWZD9fZIJysFU7GRUDeDFLJzrtxH5cd3kK5LQ7ipO72h-riLOsVP7OcSWu1cZJZAeGfFjzPHaRpRc5skvOAbAxSX_K3BHtAXizIoPhYzTGlr2ZwJlIKkm_No4A87ECy4ES0axIUC4hegc8Kq6uUcvKtHS4ecay-Kfn4cr6ekxvjo4P9bH_3cO8JuclxKzITIecbZNRczPxTCNWa_FmvH5ScXrVK_gErllT4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB7qFsUX8W606giKIMSdTGYykwcRa1taq0sRC32Lk5lJXXCT2mSRffdX-es8J5ddV6Rvfd0ZwmHPd25zboQ8N8pG3hgb5l6aUIg8DnVqIWotIpNHKhbGYKPwp0myfyw-nMiTDfJ76IXBsspBJ7aK2lUW38jHMUfVCbKbjIu-LOJoZ-_t2Y8QN0hhpnVYp9FB5NAvfkL4Vr852AFev-B8b_fL-_2w3zAQGnDUm9D5QjjNdKFZrrRLJHgnsmDeSVzGxdLCMOdE5KXDdGCcemm1hohF-1Q6UCMxfPcK2VRgFcWIbG7vTo4-r154kliBNe1TqWAHxrNuOnP9uo1CQuyyH5l6xtdsYrs64H_-7r9lm3_Zwb2b5EbvwNJ3HeJukQ1f3iZXu5WWizvkV9vRG2Kvc01NO_HE17QqKDia9HTe0Nm0G_3UGDh2dOYbgCE2Qtd0WtKht5zi-_Dy0FK3qNECI4pC0yPKO4oQbSqghH7H-hLap5vukuNL4cM9Miqr0j8gVKcsVR7cyMjhYB1lIq-Z8joXkTKJjAPyEv_yrBfVOmujIK6zgTlZy5yMi4C8GriSnXWjPy66vI18W17Eqd3tD9X5adYrgcxyJq3VxklmBbiCWvA8dxCyFTmzSc4DsjVwfUXfCvgBebY8BiWAmR1T-moOdyKlIBDXPArI_Q4kS0pEuzJBsYDoNfiskbp-Uk6_tYPGI46ZOCUfXkzXU3INRDH7eDA5fESuc1yQzETI-RYZNedz_xi8tiZ_0osHJV8vWyL_AMHcWSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multi-omics+analyses+of+the+gut+microbiota+and+metabolites+in+children+with+metabolic+dysfunction-associated+steatotic+liver+disease&rft.jtitle=mSystems&rft.au=Du%2C+Landuoduo&rft.au=Zhang%2C+Kaichuang&rft.au=Liang%2C+Lili&rft.au=Yang%2C+Yi&rft.date=2025-04-22&rft.pub=American+Society+for+Microbiology&rft.eissn=2379-5077&rft.volume=10&rft.issue=4&rft_id=info:doi/10.1128%2Fmsystems.01148-24&rft_id=info%3Apmid%2F40084870&rft.externalDocID=PMC12013275
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-5077&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-5077&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-5077&client=summon